Growth & Performance Peptides
Growth hormone secretagogues and gonadotropins for research on the hypothalamic-pituitary-IGF-1 axis. Selective GHRH mimetics such as Sermorelin and Tesamorelin, GHRP agonists such as Ipamorelin and the popular CJC-1295/Ipamorelin combination (with and without DAC), plus HGH itself and HCG for gonadal research. All compounds are used in preclinical models for endocrine signalling pathways, body-composition endpoints and regeneration markers. Supplied with a batch-specific Janoshik third-party certificate of analysis.
All products
Related research
June 25, 2026
Melanotan-2 in Summer 2026: What the New Case Reports and Regulatory Warnings Really Say
Tanning season is here, and Melanotan-2 is back in the headlines. What the 2026 case report actually shows, what the 2025 UK regulatory warning documents, and why identity and purity are the real question.
Read more →
June 4, 2026
Sermorelin vs CJC-1295 vs Ipamorelin: Which GH Peptide for Your Research Goal?
Sermorelin, CJC-1295 (No-DAC) and Ipamorelin compared: half-life, GH profile, selectivity and evidence. The decision guide for researchers.
Read more →
May 22, 2026
Tesamorelin: Visceral Belly Fat, Liver Fat (MASLD) and a New Cognition Finding
Tesamorelin in a 2026 research overview: an approved GHRH analog against visceral fat, data on liver fat in MASLD, and a cognition finding not confirmed in a 2025 randomized trial.
Read more →







